对治疗肥胖症中的埃诺沙巴林剂量进行系统审查
Maya R Chilbert1,2, Kimberly Zammit3,4, Uzma Ahmed5
1University at Buffalo School of Pharmacy and Pharmaceutical Sciences, 273 Pharmacy Building, Buffalo, NY, 14214, USA. mayahols@buffalo.edu.
Journal of thrombosis and thrombolysis
|February 25, 2024
概括
接受标准埃诺沙巴林剂量的肥胖患者有超治疗水平的风险. 减少基于体重的剂量可能会改善治疗性抗Xa水平,并减少该群体的出血事件.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 肥胖医学 肥胖医学
背景情况:
- 在肥胖患者中,标准的埃诺沙巴林剂量可能会导致超治疗水平,这是由于其水友性质和对分布体积的最小影响.
- 目前关于肥胖个体 (BMI ≥40 kg/m2或体重>100 kg) 基于体重的最佳埃诺沙巴林剂量的数据和建议是不一致的.
- 肥胖症在使用埃诺沙来实现治疗性抗凝剂方面存在独特的挑战,平衡过量和不足剂量的风险.
结论:
- 减少基于体重的素剂量策略似乎更有效地实现肥胖患者的治疗性抗Xa水平.
- 较低的埃诺沙巴林剂量与该人群中出血事件的发生率降低有关.
- 需要进一步的研究来确定治疗性埃诺沙巴林在肥胖患者的最终最佳剂量指南,以尽量减少血栓和出血风险.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K


